New startup ideas · Health and bio · Healthcare and bio
startup idea
Halomark
A wearable that reads hormones continuously, the way CGMs read glucose.
Halomark builds a subcutaneous aptamer-based sensor and patch reader that tracks cortisol, thyroid and reproductive hormones continuously instead of at single blood-draw timepoints.
- Hardware
- Consumer
- $1-10B market
- Creates a new category
- US first
3/5
venture judge
21
similar startups, last 2 years (63 all-time)
95%
of 2 nearest real companies still alive
yes
8 matching federal grants and programs
Direction supported by government programs and grants
Scorecard
One score that balances how trendy the idea is, the demand for it and its potential for 100x, with competition measured relative to every other idea in the catalog. Recent startup trends first, government priorities second.
53
Idea Score, 0-100 · raw 32.2 x 1.64
Crowded
competition: more crowded than 88% of ideas · headwind x0.56
+3.9
government priorities, secondary (42 matching grants)
Trend
55
Is the wave forming now? 2025-26 entrants vs 2023-24, rounds since 2025, the sector's live-batch direction, the 2026 trend analyst.
- Entrants 2025-26 vs 2023-24 (similar companies)51
- Rounds announced 2025+ in the sector68
- Sector direction (live batch)100
- 2026 trend analyst0
Demand
43
Does anyone want it? YC's current RFS, companies already paid for something similar, the operator judge, founders' yes-rate in decks, readers who would run the test.
- YC asks for it (current RFS: idea / sector)30
- Someone already pays (similar companies, recent / all-time)100
- Operator judge: real pain0
100x potential
55
Can it return a fund? The venture judge (double weight), market-size and moat axes, neighbours still alive, the technologist judge.
- Venture judge50
- Market size axis33
- Moat axis80
- Neighbours still alive65
- Technologist judge50
Score = 100 x cbrt(Trend x Demand x 100x) x (1 - 0.5 x crowding) + government bonus (max 5), calibrated so the 95th-percentile idea scores 90 (order never changes). A geometric mean: a weak pillar cannot be papered over. Percentiles are among the 272 ideas in the catalog; the terms matched were wearable, reads, hormones, continuously, cgms, read, glucose, builds.
The idea in full
- What
- Halomark builds a subcutaneous aptamer-based sensor and patch reader that tracks cortisol, thyroid and reproductive hormones continuously instead of at single blood-draw timepoints. Consumers buy it directly online on a subscription, the way glucose monitors are now bought, and see hormone curves rather than one number from one morning. The hard part is sensor chemistry stability in interstitial fluid plus the fab line to make patches at consumer prices.
- Why now
- Sub-Q Bionics raised $1.5M pre-seed on 2026-04-01 for subcutaneous biomedical technology and Illume Labs (yc S26) is selling a 24/7 personal health and longevity companion with no continuous chemistry underneath it, so the consumer demand and the sensing substrate are arriving at the same time.
- Wedge: first customer and entry point
- Perimenopausal women who currently pay for repeated single-timepoint hormone panels that contradict each other: one analyte, direct-to-consumer, general wellness positioning while the de novo submission runs.
- Path to 100x
- Continuous hormone measurement is a $1-10B market today because it does not exist as a purchasable thing, and the company that names and owns it takes the position CGM makers took when glucose curves became a consumer product. The moat is the direct subscription channel: hundreds of thousands of recurring patch buyers acquired before any incumbent has a cleared competing sensor.
- Ceiling
- FDA holds the consumer claim to wellness-only language and cartridge cost stays high, leaving a high-priced enthusiast product rather than a category.
- Closest real companies, as the generator saw them
- Sub-Q Bionics works on subcutaneous biomedical hardware but not a consumer-owned continuous hormone product; Illume Labs and Gutgutgoose (yc S26) sell consumer health subscriptions on top of external data rather than generating their own continuous signal.
- Main risk
- Aptamer sensors drift within days in vivo, so the curve is uncalibrated after week one and the whole category claim collapses.
Five judges
Each judge scores every idea in the catalog with a named rubric; the venture judge decides whether a card is shown at all (4-5 is venture-grade).
Venture investor
3/5
CGM-scale category creation is the right shape, but aptamer drift within days makes the whole thesis a single binary science bet.
Bootstrapper
1/5
Subcutaneous aptamer sensors, a fab line and an FDA de novo submission is the maximum capital and regulatory path available.
Operator
1/5
No line item exists for continuous hormone curves today, and aptamer drift within days means the subscription has nothing to sell.
Technologist
3/5
Aptamer sensors that drift within days in interstitial fluid means the product hinges on a stability breakthrough that does not exist today.
Risk
1/5
Selling a subcutaneous hormone sensor direct to consumers under wellness language while the de novo runs is unlicensed exposure on an implanted device.
trends
1/5
A $1.5M pre-seed at Sub-Q Bionics is the entire timing case; continuous hormone sensing chemistry has no 2025-2026 unlock in evidence.
Similar startups in the directory
Companies whose pitch matches most of the idea's terms (wearable, reads, hormones, continuously, cgms, read, glucose, builds): 63 all-time, 21 from the last two years. Same matching as Idea Check.
AI Native Shopify
We're building the first continuous hormone monitor.
The AI operating system for commodity operations
We give birds the vision to stop window collisions
Developer of a content marketing platform designed to personalize branded content across websites, email, paid media and more, The company's content marketing platform uses machine learning technology that automatically surfaces the most personally relevant content to the visitors across channels and continually improves content recommendations of the visitors to keep them coming back and reading more of the content. enabling brands to build strong content-based relationships, provide measurable audience and content insights and drive quantifiable results.
Build everyday back-office agents on one live model of your books
Vibecode + deploy HIPAA-compliant internal tools, no eng team needed
AI that finds value creation opportunities across enterprise…
The first wearable that reads your emotions to enhance your EQ.
An AI primary care doctor in your pocket
Ziva - AI Plugin for Godot Game Engine | Generate Code, Build Scenes, Debug Errors
End-to-end workspace to accelerate scientific discovery
The generator's reference companies
Real companies the model named as closest when it wrote the card, with their fate. A check mark is a company the radar could verify in its directory.
- Sub-Q Bionics
- Illume Labs ✓ 2026
- Gutgutgoose ✓ 2026
Public money in this direction
US federal grants, SBIR/STTR awards and open opportunities from the radar's public-money feed, matched to the idea's terms; the sector totals give the context.
8
grants and programs matching the idea
1127
startup-relevant grants in Healthcare and bio
$590M
awarded in the sector, tracked
130
opportunities open now in the sector
- A Specialized Risk-Stratification Platform and Tailored Diabetes Prevention Program for Post-Partum to Reduce Progression to Type 2 Diabetesawardhigh relevance
NIH / NIMHD · SBIR phase II · $314K · posted 2025-09-17
- A Specialized Risk-Stratification Platform and Tailored Diabetes Prevention Program for Post-Partum to Reduce Progression to Type 2 Diabetesawardhigh relevance
NIH / NIMHD · SBIR phase II · $1M · posted 2025-09-17
- Development and Validation of Efficient Algorithms for Real-Time Glucose Monitoring on a Multi-Sensor Integrated Platformawardhigh relevance
NIH / NIDDK · SBIR phase I · $285K · posted 2025-09-01
- MetaDx: Rapid Diagnosis of Fungal, Bacterial, and Viral Infections Using Whole Metagenomic Sequencingawardhigh relevance
NIH / NIAID · SBIR phase I · $295K · posted 2026-06-12
- I-Corps: Translation Potential of a marine-adapted radio frequency identification (RFID) and analytics platform for digital inventory management in shellfish aquacultureawardhigh relevance
National Science Foundation · I-Corps · $50K · posted 2026-08-19
- Wearable long duration postoperative topical cryotherapy for enhanced pain managementawardhigh relevance
NIH / NCCIH · SBIR phase I · $313K · posted 2026-08-17
National Science Foundation · I-Corps · $50K · posted 2026-08-10
NIH / NIEHS · SBIR phase I · $307K · posted 2026-08-01
Market signal
What the radar sees in Healthcare and bio: new companies by cohort year, the forming YC batch, and outcomes since the February snapshot.
Healthcare and bio · 130 → 118 → 216 → 173 → 71 new companies 2022 → 2026 · 92% aliveYC S26: 14 in this cluster, 6% of the batch (was 4% in X26) (F26 is still forming: 21 listed)Since February, of 444 YC companies here: 4 acquired, 5 shut down, 37 rewrote their pitch
Design attributes
The card is one cell of a designed set: every axis below was chosen before the text was written, and the text had to realize it.
- Buyer
- Consumer
- Business model
- Hardware
- Path to 100x
- Creates a new category
- Market size
- $1-10B market
- Capital intensity
- Capital-heavy (hardware, bio, infra)
- Speed to revenue
- Revenue in 1-3 years
- Technical depth
- Deep tech: ML, hardware, bio
- Go-to-market
- Self-serve
- Moat
- Distribution moat
- Geography
- US first
- Regulation
- Heavily regulated
- Vibe
- Hot space
Listed under
An idea sits in its own sector and in any sector its text clearly touches.
More ideas like this
Health and bio · Healthcare and bio
Bylaw Health
The licensed medical group behind your API call, in fifty states.
Bylaw Health holds the professional corporations, state clinician licenses, supervision agreements and payer enrollments in every US state, and exposes them as endpoints: create a clinician, attach a supervising physician, enroll a location with a payer, submit an encounter under a compliant entity.
Health and bio · Healthcare and bio
Bayworks
Licensed GMP manufacturing bays for personalized therapies, sold as bookable capacity.
Bayworks builds standardized, FDA-registered cleanroom modules inside hospital systems and partner CDMO sites, then runs a marketplace where drug sponsors book manufacturing slots by the batch instead of signing multi-year suite reservations.
Health and bio · Healthcare and bio
Assaygrid
Predicts which lab runs will fail before reagents are consumed, across every instrument vendor.
Assaygrid connects to the instrument fleet of pharma, biotech and industrial R&D organizations, learns from run telemetry, reagent lots, operator steps and outcomes, and flags runs likely to fail plus the parameter change that fixes them.
Health and bio · Healthcare and bio
Overturn
Agents that fight payer denials for health systems, then sell what wins.
Overturn deploys an agent workforce inside a health system's revenue cycle that reads each denial, pulls the governing payer medical policy, assembles the clinical record and files the appeal, working through existing EHR and clearinghouse integrations rather than new infrastructure.
Health and bio · Healthcare and bio
Labmesh
Agents that design, order and run preclinical experiments across a global lab network.
Labmesh gives a biotech or pharma scientist an agent that takes a hypothesis, decomposes it into assays, prices and routes each assay to a contract lab on its network, tracks samples, and returns structured results with the raw instrument files.
Health and bio · Healthcare and bio
ChartRail
The consented medical-records rail every AI clinic runs on.
An API that lets AI-native care companies pull a patient's complete medical record with verifiable consent, by operating as a qualified participant in the national health information exchange framework and as a registered clearinghouse.
Fictional company written 2026-08-23 from MarkosWeb data; the companies, grants and numbers around it are real and tracked. Treat the idea as a research prompt, not a plan.